Experts (Institut Jules Bordet): Difference between revisions
From Beacon
No edit summary |
m (Update categories.) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> | |||
<span style="display:none">forpatients</span> | |||
<span style="display:none">belgiumcountry</span> | |||
<span style="display:none">hospital</span> | |||
<span style="display:none">cancer center</span> | |||
Go back to [[Institut Jules Bordet]] page | Go back to [[Institut Jules Bordet]] page | ||
| Line 81: | Line 81: | ||
'''[https://www.bordet.be/fr/clinical-trials-conduct-unit-ctcu Clinical trials conduct unit (CTCU)]''' | '''[https://www.bordet.be/fr/clinical-trials-conduct-unit-ctcu Clinical trials conduct unit (CTCU)]''' | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Latest revision as of 12:31, 6 December 2025
Go back to Institut Jules Bordet page
Care and Diagnostic Services[edit | edit source]
Anesthesiology - Resuscitation
Cancer Prevention and Screening
Cell Therapy Unit (Hematology)
Oncogenetics Clinic (Cancer Prevention and Screening)
Supportive and Palliative Care
Tobacco (Cancer Prevention and Screening)
Transplantation Unit (Hematology)
Research Laboratories and Platforms[edit | edit source]
Clinical Cell Therapy Laboratory (LTCC)
JC Heuson Breast Cancer Translational Research Laboratory (BCTL)
Laboratory of Oncology and Experimental Surgery (LOCE)
Molecular Immunology Laboratory (MIU)
Tumour Library (technological platform)
